A new imaging study of the mummified arteries of people who lived thousands of years ago revealed that their arteries were more clogged than originally thought, according to a proof-of-concept study led by a researcher with ...
Sep 23, 2019
0
48
Genotype-guided oral P2Y12 inhibition reduces bleeding without raising clotting risk in heart attack patients undergoing stent implantation, according to late breaking results from the POPular Genetics trial presented in ...
Sep 4, 2019
0
1
Left ventricular hypertrophy (LVH), also known as an enlarged heart, is associated with a nearly two times higher risk of dementia according to a recent University of Minnesota School of Public Health study published in the ...
Nov 30, 2018
0
11
A clinical trial to determine whether a smartwatch app that analyzes pulse-rate data can screen for a heart-rhythm disorder has enrolled more than 400,000 participants.
Nov 1, 2018
0
2
Arrhythmias—disruptions in the rhythm of the heartbeat—after congenital heart disease (CHD) surgery in children are common and contribute to increased morbidity and mortality.
Aug 20, 2018
0
0
Heart patients who participate in cardiac rehab programs typically do well during enrollment but tend to revert to unhealthy lifestyles once the formal gym-based regimens end.
Mar 15, 2018
0
5
Time periods by calendar related to perceived stress are associated with the incidence rate of myocardial infarction (MI), says a new nationwide registry study of 156 000 people of the Swedish population, in the database ...
Jul 6, 2017
0
0
In 2009, Minneapolis Heart Institute Foundation (MHIF), along with Allina Health, New Ulm Medical Center (NUMC) and the community of New Ulm, Minnesota, began a 10-year population health research project to learn if heart ...
Mar 14, 2016
0
17
Most patients who report statin intolerance, including muscle aches and other side effects from the cholesterol-lowering drugs, can actually tolerate drugs from this class on subsequent trials, according to research from ...
Sep 9, 2013
0
0
A re-analysis of the data from a pivotal study of rosiglitazone found no increased risk of cardiovascular events associated with the controversial diabetes drug, according to researchers at the Duke Clinical Research Institute ...
Jun 7, 2013
0
0
